Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases.
Berghoff AS, Breckwoldt MO, Riedemann L, Karimian-Jazi K, Loew S, Schlieter F, Furtner J, Cinci M, Thomas M, Strowitzki MJ, Marmé F, Michel LL, Schmidt T, Jäger D, Bendszus M, Preusser M, Wick W, Winkler F. Berghoff AS, et al. Among authors: furtner j. Neurooncol Adv. 2020 Mar 16;2(1):vdaa038. doi: 10.1093/noajnl/vdaa038. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642693 Free PMC article.
Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.
Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, Mert A, Di Ieva A, Tomanek B, Prayer D, Marosi C, Hainfellner JA, Knosp E, Wolfsberger S. Widhalm G, et al. Among authors: furtner j. Neurosurg Rev. 2012 Jul;35(3):381-91; discussion 391. doi: 10.1007/s10143-012-0374-5. Epub 2012 Mar 10. Neurosurg Rev. 2012. PMID: 22407140
High plasma-GFAP levels in metastatic myxopapillary ependymoma.
Ilhan-Mutlu A, Berghoff AS, Furtner J, Dieckmann K, Slavc I, Czech T, Marosi C, Wagner L, Preusser M. Ilhan-Mutlu A, et al. Among authors: furtner j. J Neurooncol. 2013 Jul;113(3):359-63. doi: 10.1007/s11060-013-1134-2. Epub 2013 Apr 29. J Neurooncol. 2013. PMID: 23624779
Invasion patterns in brain metastases of solid cancers.
Berghoff AS, Rajky O, Winkler F, Bartsch R, Furtner J, Hainfellner JA, Goodman SL, Weller M, Schittenhelm J, Preusser M. Berghoff AS, et al. Among authors: furtner j. Neuro Oncol. 2013 Dec;15(12):1664-72. doi: 10.1093/neuonc/not112. Epub 2013 Sep 30. Neuro Oncol. 2013. PMID: 24084410 Free PMC article.
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.
Furtner J, Schöpf V, Seystahl K, Le Rhun E, Rudà R, Roelcke U, Koeppen S, Berghoff AS, Marosi C, Clement P, Faedi M, Watts C, Wick W, Soffietti R, Weller M, Preusser M. Furtner J, et al. Neuro Oncol. 2016 Mar;18(3):401-7. doi: 10.1093/neuonc/nov183. Epub 2015 Sep 9. Neuro Oncol. 2016. PMID: 26354929 Free PMC article.
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.
Furtner J, Berghoff AS, Albtoush OM, Woitek R, Asenbaum U, Prayer D, Widhalm G, Gatterbauer B, Dieckmann K, Birner P, Aretin B, Bartsch R, Zielinski CC, Schöpf V, Preusser M. Furtner J, et al. Eur Radiol. 2017 Aug;27(8):3167-3173. doi: 10.1007/s00330-016-4707-6. Epub 2017 Jan 3. Eur Radiol. 2017. PMID: 28050694 Free PMC article.
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.
Poetsch N, Woehrer A, Gesperger J, Furtner J, Haug AR, Wilhelm D, Widhalm G, Karanikas G, Weber M, Rausch I, Mitterhauser M, Wadsak W, Hacker M, Preusser M, Traub-Weidinger T. Poetsch N, et al. Among authors: furtner j. Neuro Oncol. 2018 Feb 19;20(3):411-419. doi: 10.1093/neuonc/nox177. Neuro Oncol. 2018. PMID: 29016947 Free PMC article.
135 results